Aura Biosciences, Inc.

NASDAQ:AURA

Biotechnology

Healthcare
$7.14 -1.43%

-$0.09 today

Market cap
$743.09M
Beta
0.39
P/E (TTM)
-3.7
EPS (TTM)
-$1.67
52W Low $4.73High $9.54

Volume 0.69M

Average 0.52M

Balance Sheet

Inspect the capital base behind the business.

Assets

$169.43M

FY 2025 · Annual

-7.2% YoY

Liabilities

$32.52M

FY 2025 · Annual

+6.5% YoY

Equity

$136.91M

FY 2025 · Annual

-9.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents149.06M121.58M41.06M31.69M59.52M
Short-term Investments067.23M185.09M119.4M84.73M
Net Receivables00000
Inventory00000
Other Current Assets89K5.72M3.83M1.83M1.18M
Total Current Assets153.7M196.7M231.79M160.62M149.74M
Property, Plant & Equipment (Net)6.2M26.04M22M20.59M18.45M
Goodwill00000
Intangible Assets00000
Long-term Investments0768K000
Tax Assets00000
Other Non-current Assets125K423K1.28M1.29M1.24M
Total Non-current Assets6.33M27.23M23.28M21.88M19.69M
Total Assets160.03M223.94M255.08M182.5M169.43M
Account Payables2.4M2.92M1.79M2.3M1.55M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities2.65M3.03M935K618K6.25M
Total Current Liabilities7.36M10.46M12.36M14.91M18.38M
Long-term Debt000014.13M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities360K17.9M16.87M15.62M14.13M
Total Liabilities7.72M28.35M29.23M30.53M32.52M
Common Stock00000
Retained Earnings(152.14M)(210.9M)(287.31M)(374.23M)(480.42M)
Accumulated OCI0(72K)539K263K(102K)
Other Stockholders Equity001K00
Minority Interest00000
Total Equity152.32M195.58M225.85M151.97M136.91M
Total Debt975K20.86M19.56M18.77M17.38M
Net Debt(148.09M)(100.72M)(21.51M)(12.92M)(42.14M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$84.8M
Short-term Investments$29.9M
Other Current$3.8M
Total Current Assets$118.5M
PP&E (Net)$17.9M
Other Non-current$1.3M
Total Non-current Assets$19.2M
Total Assets$137.7M

Analysis

Selected assets total $137.7M for Latest. The largest visible component is Cash & Equivalents at $84.8M, about 61.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
10-QQuarterly reportNov 9, 2026
8-KCurrent reportNov 9, 2026
SC 13GSC 13G filingOct 27, 2026
SC 13GSC 13G filingOct 1, 2026

How much cash does AURA have?

Aura Biosciences, Inc. (AURA) reported $59.52M in cash and equivalents in fiscal 2025.

How much debt does AURA carry?

Aura Biosciences, Inc. (AURA) reported $17.38M of total debt, with net debt of -$42.14M.